468
Views
46
CrossRef citations to date
0
Altmetric
Original Article

Cytotoxicity and morphological transforming potential of cobalt nanoparticles, microparticles and ions in Balb/3T3 mouse fibroblasts: an in vitro model

, , , , , , , , , , & show all
Pages 455-464 | Received 10 Dec 2012, Accepted 01 Apr 2013, Published online: 15 May 2013

References

  • Beer C, Foldbjerg R, Hayashi Y, Sutherland DS, Autrup H. Toxicity of silver nanoparticles - nanoparticle or silver ion? Toxicol Lett 2012. 208:286–292.
  • Bernardini G, Cattaneo AG, Sabbioni E, Di Gioacchino M, Chiriva-Internati M, Gornati R. 2011. Toxicology of engineered metal nanoparticles. In: Sahu SC and Casciano D, editors. Handbook of system toxicology vol II. Chichester: Wiley & Sons Ltd. 729–742.
  • Bouchard LS, Anwar MS, Liu GL, Hann B, Xie ZH, Gray J W, et al. 2009. Picomolar sensitivity MRI and photoacoustic imaging of cobalt nanoparticles. Proc Natl Acad Sci USA 106:4085–4089.
  • Brubacher D, Moser U, Jordan P. 2000. Vitamin C concentrations in plasma as a function of intake: a meta-analysis. Int J Vitam Nutr Res 70:226–237.
  • Brunner TJ, Wick P, Manser P, Spohn P, Grass RN, Limbach LK, et al. 2006. In vitro cytotoxicity of oxide nanoparticles: comparison to asbestos, silica, and the effect of particle solubility. Environ Sci Technol 40:4374–4381.
  • Bucher JR, Hailey JR, Roycroft JR, Haseman JK, Sills RC, Grumbein SL, et al. 1999. Inhalation toxicity and carcinogenicity studies of cobalt sulfate. Toxicol Sci 49:56–67.
  • Cattaneo AG, Gornati R, Sabbioni E, Chiriva-Internati M, Cobos E, Jenkins MR, et al. 2010. Nanotechnology and human health: risks and benefits. J Appl Toxicol 30:730–744.
  • Chou NH, Ross PN, Bell AT, Tilley TD. 2011. Comparison of cobalt- based nanoparticles as electrocatalysts for water oxidation. ChemSusChem 4:1566–1569.
  • Colognato R, Bonelli A, Ponti J, Farina M, Bergamaschi E, Sabbioni E, et al. 2008. Comparative genotoxicity of cobalt nanoparticles and ions on human peripheral leukocytes in vitro. Mutagenesis 23:377–382.
  • Combes R, Balls M, Curren R, Fischbach M, Fusenig N, Kirkland D, et al. 1999. Cell transformation assays as predictors of human carcinogenicity. The report and recommendations of ECVAM Workshop 39. ATLA 27:745–767.
  • Di Gioacchino M, Verna N, Gornati R, Sabbioni E, Bernardini G. 2009. Metal nanoparticle health risk assessment. In: Sahu SC, Casciano DA, editors. Nanotoxicity. Chichester: John Wiley & Sons Ltd. Chapter 24, pp 519–541.
  • EURL ECVAM (2012), Recommendation of 14.03.12 on three Cell Transformation Assays (CTA) Using Syrian Hamster Embryo Cells (SHE) and the BALB/c 3T3 Mouse Fibroblast Cell Line for in vitro Carcinogenicity Testing.
  • Garrick MD, Dolan KG, Horbinski C, Ghio AJ, Higgins D, Porubcin M, et al. 2003. DMT1: a mammalian transporter for multiple metals. Biometals 16:41–54.
  • Hartung T, Sabbioni E. 2011. Alternative in vitro assays in nanomaterial toxicology. Wiley Interdiscip Rev Nanomed Nanobiotechnol 3:545–573.
  • Henkler F, Brinkmann J, Luch A. 2010. The role of oxidative stress in carcinogenesis induced by metals and xenobiotics. Cancers 2:376–396.
  • Iablokov V, Beaumont SK, Alayoglu S, Pushkarev VV, Specht C, Gao J, et al. 2012. Size-controlled model co nanoparticle catalysts for CO2 hydrogenation: synthesis, characterization, and catalytic reactions. Nano Lett 12:3091–3096.
  • IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. 2006. Cobalt in hard metals and cobalt sulfate, gallium arsenide, indium phosphide and vanadium pentoxide. IARC Monogr Eval Carcinog Risks Hum 86:1–294.
  • Jiang H, Liu F, Yang H, Li Y. 2012. Effects of cobalt nanoparticles on human T cells in vitro. Biol Trace Elem Res 146:23–29.
  • Kerckaert GA, LeBoeuf RA, Isfort RJ. 1996. Use of the Syrian hamster embryo cell transformation assay for determining the carcinogenic potential of heavy metal compounds. Fundam Appl Toxicol 34:67–72.
  • Klostergaard J, Seeney CE. 2012. Magnetic nanovectors for drug delivery. Nanomedicine 8:S37–S50.
  • Krug HF, Wick P. 2011. Nanotoxicology: an interdisciplinary challenge. Angew Chem Int Ed Engl 50:1260–1278.
  • Li YF, Chen C, Qu Y, GaoY Li B, Zhao Y, et al. 2008. Metallomics, elementomics, and analytical techniques. Pure Appl Chem 80: 2577–2594.
  • Lison D, Carbonnelle P, Mollo L, Lauwerys R, Fubini B. 1995. Physicochemical mechanism of the interaction between cobalt metal and carbide particles to generate toxic activated oxygen species. Chem Res Toxicol 8:600–606.
  • Lison D, De Boeck M, Verougstraete V, Kirsch-Volders M. 2001. Update on the genotoxicity and carcinogenicity of cobalt compounds. Occup Environ Med 58:619–625.
  • Lison D, Lauwerys R, Demedts M, Nemery B. 1996. Experimental research into the pathogenesis of cobalt/hard metal lung disease. Eur Respir J 9:1024–1028.
  • Lubick N. 2008. Nanosilver toxicity: ions, nanoparticles or both? Environ Sci Technol 42:8617.
  • Mazzotti F, Sabbioni E, Ghiani M, Cocco B, Ceccatelli R, Fortaner S. 2001. In vitro assessment of cytotoxicity and carcinogenic potential of chemicals: evaluation of the cytotoxicity induced by 58 metal forms in the BALB/3T3 cell line. Altern Lab Anim 29: 601–611.
  • Méplan C, Richard MJ, Hinaut P. 2000. Metalloregulation of the tumor suppression protein p53: zinc mediates the renaturation of p53 after exposure to metal chelators in vitro and in intact cells. Oncogene 19:5227–5236.
  • Mo Y, Zhu X, Hu X, Tollerud DJ, Zhang Q. 2008. Cytokine and NO release from peripheral blood neutrophils after exposure to metal nanoparticles: in vitro and ex vivo studies. Nanotoxicology 2:79–87.
  • Monteiller C, Tran L, MacNee W, Faux S, Jones A, Miller B, et al. 2007. The pro-inflammatory effects of low-toxicity low solubility particles, nanoparticles and fine particles, on epithelial cells in vitro: the role of surface area. Occup Environ Med 64:609–615.
  • Moulis JM. 2010. Cellular mechanisms of cadmium toxicity related to the homeostasis of essential metals. Biometals 23:877–896.
  • Nelo M, Sowpati AK, Palukuru VK, Juuti J, Jantunen H. 2010. Formulation of screen printable cobalt nanoparticle ink for high frequency applications. Prog electromagnetic res 110:253–266.
  • Papageorgiou I, Brown C, Schins R, Singh S, Newson R, Davis S, et al. 2007. The effect of nano- and micron-sized particles of cobalt-chromium alloy on human fibroblasts in vitro. Biomaterials 28:2946–2958.
  • Papis E, Gornati R, Prati M, Ponti J, Sabbioni E, Bernardini G. 2007. Gene expression in nanotoxicology research: Analysis by differential display in BALB3T3 fibroblasts exposed to cobalt particles and ions. Toxicol Lett 170:185–192.
  • Papis E, Rossi F, Raspanti M, Dalle-Donne I, Colombo G, Milzani A, et al. 2009. Engineered cobalt oxide nanoparticles readily enter cells. Toxicol Lett 189:253–259.
  • Park EJ, Yi J, Kim Y, Choi K, Park K. 2010. Silver nanoparticles induce cytotoxicity by a Trojan-horse type mechanism. Toxicol In Vitro 24:872–878.
  • Petrarca C, Perrone A, Verna N, Verginelli F, Ponti J, Sabbioni E, et al. 2006. Cobalt nano-particles modulate cytokine in vitro release by human mononuclear cells mimicking autoimmune disease. Int J Immunopathol Pharmacol 19:11–14.
  • Pisanic TR, Blackwell JD, Shubayev VI, Fiñones RR, Jin S. 2007. Nanotoxicity of iron oxide nanoparticle internalization in growing neurons. Biomaterials 28:2572–2581.
  • Ponti J, Sabbioni E, Munaro B, Broggi F, Marmorato P, Franchini F, et al. 2009. Genotoxicity and morphological transformation induced by cobalt nanoparticles and cobalt chloride: an in vitro study in Balb/3T3 mouse fibroblasts. Mutagenesis 24:439–445.
  • Puntes VF, Gorostiza P, Aruguete DM, Bastus NG, Alivisatos AP. 2004. Collective behaviour in two-dimensional cobalt nanoparticle assemblies observed by magnetic force microscopy. Nate Mat 3:263–268.
  • Puntes VF, Krishnan KM, Alivisatos AP. 2001. Colloidal nanocrystal shape and size control: the case of cobalt. Science 291:2115–2117.
  • Rahman I, Kode A, Biswas SK. 2007. Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method. Nat Protoc 1:3159–3165.
  • Sabbioni E, Fortaner S, Farina M, Del Torchio R, Petrarca C, Bernardini G, et al. 2012. Interaction with culture medium components, cellular uptake and intracellular distribution of cobalt nanoparticles, microparticles and ions in Balb/3T3 mouse fibroblasts. Nanotoxicology; Epub ahead of print.
  • Sabbioni E, Pietra R, Minoia C, Edel J. 1993. Application of nuclear, radiochemical and spectrochemical techniques in metal toxicology. J Trace Micro Tech 11:217–233.
  • Sayes CM, Gobin AM, Ausman KD, Mendez J, West JL, Colvin VL. 2005. Nano-C60 cytotoxicity is due to lipid peroxidation. Biomaterials 36:7587–7595.
  • Simonsen LO, Harbak H, Bennekou P. 2012. Cobalt metabolism and toxicology–a brief update. Sci Total Environ 432:210–215.
  • Studer AM, Limbach LK, Van Duc L, Krumeich F, Athanassiou EK, Gerber LC, et al. 2010. Nanoparticle cytotoxicity depends on intracellular solubility: comparison of stabilized copper metal and degradable copper oxide nanoparticles. Toxicol Lett 197:169–174.
  • Tanaka N, Bohnenberger S, Kunkelmann T, Munaro B, Ponti J, Poth A, et al. 2011. Prevalidation study of the BALB/c 3T3 cell transformation assay for assessment of carcinogenic potential of chemicals. Mutat Res 744:20–29.
  • Valko M, Morris H, Cronin MTD. 2005. Metals, toxicity and oxidative stress. Curr Med Chem 12:1161–1208.
  • Witkiewicz-Kucharczyk A, Bal W. 2006. Damage of zinc fingers in DNA repair proteins, a novel molecular mechanism in carcinogenesis. Toxicol Lett 162:29–42.
  • Zhao F, Zhao Y, Liu Y, Chang X, Chen C, Zhao Y. 2011. Cellular uptake, intracellular trafficking, and cytotoxicity of nanomaterials. Small 23:1322–1337.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.